We are live on ! Find out more
BEAT

BioTelemetry, Inc.
BEAT

Delisted

BEAT was delisted on the 8th of February, 2021.

167 hedge funds and large institutions have $430M invested in BioTelemetry, Inc. in 2016 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 55 increasing their positions, 58 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

187% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 15

20% more capital invested

Capital invested by funds: $358M → $430M (+$72.2M)

20% more funds holding

Funds holding: 139167 (+28)

5% less repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 58

15% less call options, than puts

Call options by funds: $3.88M | Put options by funds: $4.58M

50% less funds holding in top 10

Funds holding in top 10: 42 (-2)

Holders
167
Holders Change
+28
Holders Change %
+20.14%
% of All Funds
4.46%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
43
Increased
55
Reduced
58
Closed
15
Calls
$3.88M
Puts
$4.58M
Net Calls
-$697K
Net Calls Change
+$1.01M
Name Holding Trade Value Shares
Change
Change in
Stake
Charles Schwab
51
Charles Schwab
California
$1.95M +$1.25M +66,159 +171%
FPC
52
Falcon Point Capital
California
$1.82M -$297K -15,741 -13%
Bank of America
53
Bank of America
North Carolina
$1.78M -$259K -13,744 -13%
FLAM
54
First Light Asset Management
Minnesota
$1.76M -$3.02M -160,170 -63%
Morgan Stanley
55
Morgan Stanley
New York
$1.75M -$543K -28,797 -23%
DC
56
Deere & Company
Illinois
$1.65M -$267K -14,136 -14%
BA
57
BlackRock Advisors
Delaware
$1.61M +$379K +20,097 +30%
GIPM
58
G2 Investment Partners Management
New York
$1.61M -$1.01M -53,363 -38%
CAM
59
ClariVest Asset Management
California
$1.51M +$1.53M +81,368 New
DCM
60
DAFNA Capital Management
California
$1.49M -$377K -20,000 -20%
SAM
61
Sawgrass Asset Management
Florida
$1.47M -$286K -15,150 -16%
PPA
62
Parametric Portfolio Associates
Washington
$1.36M -$253K -13,437 -15%
TCM
63
Timpani Capital Management
Wisconsin
$1.32M -$207 -11 -0%
Citadel Advisors
64
Citadel Advisors
Florida
$1.3M +$352K +18,677 +36%
JP Morgan Chase
65
JP Morgan Chase
New York
$1.27M +$1.29M +68,453 New
MAG
66
Millrace Asset Group
Pennsylvania
$1.19M -$562K -29,805 -32%
FMBTD
67
First Midwest Bank Trust Division
Illinois
$1.18M
Goldman Sachs
68
Goldman Sachs
New York
$1.15M +$953K +50,545 +438%
CCM
69
Cadence Capital Management
Massachusetts
$1.1M +$169K +8,965 +18%
CIP
70
Convergence Investment Partners
Florida
$1.07M +$1.09M +57,788 New
California State Teachers Retirement System (CalSTRS)
71
California State Teachers Retirement System (CalSTRS)
California
$1.06M +$13.2K +700 +1%
PCM
72
Prelude Capital Management
New York
$1.05M +$185K +9,789 +21%
Prudential Financial
73
Prudential Financial
New Jersey
$1.01M +$1.02M +54,280 New
GPCM
74
Granite Point Capital Management
Massachusetts
$924K -$217K -11,525 -19%
CS
75
Credit Suisse
Switzerland
$889K -$1.01M -53,468 -53%

BEAT Hedge Fund Activity: Q3 2016 in Review

167 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in BioTelemetry, Inc. (BEAT) for Q3 2016, worth a combined $430M — up 20% from $358M a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new BEAT positions and 15 closed out — a net gain of 28 holders — while 55 added to existing stakes and 58 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $23.3M. The largest seller was Cannell Capital, cutting an estimated $7.91M.

  • 167 institutional investors held BioTelemetry, Inc. (BEAT) as of Q3 2016, up from 139 in Q2 2016.
  • Funds reported $430M of BioTelemetry, Inc. stock for Q3 2016, up 20% quarter-over-quarter.
  • 43 funds opened new BioTelemetry, Inc. positions in Q3 2016 and 15 closed out, a net change of +28 holders.
  • The largest BioTelemetry, Inc. buyer in Q3 2016 was BlackRock Fund Advisors, an estimated $23.3M added.
  • The largest BioTelemetry, Inc. seller in Q3 2016 was Cannell Capital, an estimated $7.91M sold.

Based on aggregated 13F filings for Q3 2016.